Teresa Whalen, CEO is a pharmacist by trade and has 25+ years of experience in the healthcare industry. She is a proven leader in the areas of sales leadership, developing go to market strategies and managing strategic partnerships. She is a seasoned executive with experience spanning large companies, Siemens Medical, to startups with successful exits. She is focused on strategy, business funding and developing strategic partnerships.

Todd Lorenz, a physician with over 20 years of drug development experience running large scale global trials and bringing drugs to the market. Todd has experience at large pharma and small biotech companies including J&J, Cor Therapeutics, Orexigen, Catalyst Biosciences and Corgentech.

Jodi Craigo, our Chief Science Officer and a PhD in Cellular and Molecular Biology with over 20 year of experience at the University of Pittsburgh studying Virology and Immunology, most recently served as the Director of Operations at Pitts Vaccine Research Center.

Roy Prieb is an entrepreneur with over 20 years of experience in building innovative technology and life sciences companies. Most recently, he was a co-founder and director of Kleo Pharmaceuticals, a synthetic immunotherapy company spun out from Yale University. He served as the company's COO/CFO. Roy worked as a management consultant with Boston Consulting Group. He received his BA from Harvard College and MBA from Wharton Business School.

Jim brings over 35 years of experience in the Pharmaceutical Industry. He is a Partner of both IPD, a drug discovery company, where he is CEO, and Velocity Fund Partners. Since beginning his pharmaceutical career with Dow Chemical and Chairing Research at Wyeth Jim has been involved in all aspects of our industry, in the US and internationally. Jim has an in-depth understanding of how to plan, fund, develop and bring a new products to market.